CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Shorts - general info, page-5

  1. 791 Posts.
    lightbulb Created with Sketch. 1021
    When you look at the list of most shorted stocks on the ASX, Clinuvel really stands out all alone like an Outback Dunny. Nearly all the other stocks there have debt issues, very poor outlooks and limited growth and many are far from profitable. CUV has none of these issues and unlike all those other stocks in say the top 30 they have the very strong possibility of doubling or tripling profits in the next couple of years - actually IMO they will certainly do this. So where does that leave the shorts? In a whole world of trouble as Eagle pointed out remembering 4 out of the next 6 quarterlies are the seasonal big ones and all quarterly revenues from now on will be receiving US sales so growth is guaranteed even at a time when most companies are struggling to stay afloat. Will the shorts stage an orderly exit as they strive to buyback over 4.5 MILLION shares or will it turn in a Rout, that is the main question. They have been the main sellers in the market for a long time, but those fake shares they sell have to be bought back as real shares.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.